0910-AF92 200610 The Regulatory Plan and the Unified Agenda of Federal Regulatory and Deregulatory Actions 0910 Food and Drug Administration FDA 0900 Department of Health and Human Services HHS Use of Ozone-Depleting Substances; Removal of Essential Use Designations [epinephrine] Other Significant First Time Published in The Unified Agenda Proposed Rule Stage Undetermined No 21 CFR 1.25 (revision) 40 CFR 82.4 40 CFR 82.64 40 CFR 82.66 21 USC 321 21 USC 331 21 USC 335 21 USC 342 21 USC 346a 21 USC 348 21 USC 355 42 USC 7671 et seq No NPRM 07/00/2007 No None No No NA Not Collected Wayne Mitchell H. 0910 Food and Drug Administration FDA 301 594-2041 301 827-0951 wayne.mitchell@fda.hhs.gov Suite 3037 (HFD-7), Center for Drug Evaluation and Research, 5600 Fishers Lane, HFD-7, Rockville MD 20857